CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Same-Session Angiography, Ad Hoc PCI Feasible for Select TAVRs

Published: Tue, 15 Aug 2017 16:32:13 EDT
The strategy, potentially more efficient and less costly than staged procedures, was also safe in the single-center study; observers point to possible advantages and pitfalls.
Medscape Medical News

CBO: Ending ACA Insurer Payments Would Add $194B to Deficit

Published: Tue, 15 Aug 2017 15:53:01 EDT
If insurers no longer are reimbursed for cost-sharing subsidies given to ACA enrollees, they'd be forced to raise premiums, translating into higher premium subsidies paid by the government.
News Alerts

Zika Linked to Rising Tide of Serious Neurologic Complications

Published: Tue, 15 Aug 2017 15:11:33 EDT
A rising tide of serious neurologic complications among adults in Brazil has been linked to the spread of the Zika virus, new research shows.
Medscape Medical News
Displaying results 13-15 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

What's next after CRISPR clears hurdle in quest to transplant pig organs into humans?

Published: Fri, 11 Aug 2017 18:31:19 +0000
A Boston biotech has used CRISPR to eliminate a family of viruses in pigs, which could pave the way for transplanting animal organs into humans. But scientists working in this field, known as xenotransplantation, still have plenty of hurdles to cross.

GSK jilts Ionis rare disease drug as FDA filing nears

Published: Fri, 11 Aug 2017 13:19:06 +0000
GlaxoSmithKline has jilted Ionis Pharmaceuticals just before the pair was due to file for approval of inotersen. The action furthers recently installed GSK CEO Emma Walmsley’s plan to purge the Big Pharma of its rare disease programs.

Takeda taps Texas startup for 'double whammy' cancer immunotherapies

Published: Fri, 11 Aug 2017 12:31:36 +0000
Austin, Texas-based startup Shattuck Labs is less than a year old but has already bagged its first big pharma partner with Japan's Takeda buying into its immuno-oncology platform.
Displaying results 13-15 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top